Finance

Lists
Why is 524632 up 3,34%?
Dive Deeper
524632:BOM
Shukra Pharmaceuticals Ltd
68,99 INR
+3,34%
(+2,23) 1D
16-окт., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524632...
Open
66,85 INR
High
71,81 INR
Low
66,85 INR
Mkt. cap
30,53 млд
Avg. vol.
629,78 миң
Volume
697,21 миң
P/E ratio
88,46
52-wk high
75,50 INR
52-wk low
26,30 INR
EPS
0,78 INR
No. of employees
211
Open
66,85 INR
High
71,81 INR
Low
66,85 INR
Mkt. cap
30,53 млд
Avg. vol.
629,78 миң
Volume
697,21 миң
P/E ratio
88,46
52-wk high
75,50 INR
52-wk low
26,30 INR
EPS
0,78 INR
No. of employees
211
News stories
From web sources and news partners
About Shukra Pharmaceuticals Ltd
CEO-
Employees211
Founded1993
Headquarters-
SectorPharmaceutical industry
Last report
2026-ж., 12-авг.
Fiscal period
Q1 2027
- / -
Revenue / Est. (INR)
235,22 млн / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
75,90 млн
391,35 млн
63,24 млн
235,22 млн
Cost of goods sold
20,05 млн
71,34 млн
59,40 млн
-15,35 млн
Cost of revenue
20,05 млн
71,34 млн
59,40 млн
-15,35 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
21,93 млн
26,47 млн
3,72 млн
43,89 млн
Operating expense
51,02 млн
48,88 млн
-2,56 млн
64,56 млн
Total operating expenses
71,07 млн
120,22 млн
56,84 млн
49,21 млн
Operating income
4,83 млн
271,13 млн
6,40 млн
186,01 млн
Other non operating income
1,00 миң
1,00 миң
1,00 миң
-
EBT including unusual items
1,98 млн
268,31 млн
3,82 млн
181,72 млн
EBT excluding unusual items
1,98 млн
268,31 млн
3,82 млн
181,72 млн
Income tax expense
-21,80 млн
64,67 млн
20,98 млн
52,13 млн
Effective tax rate
-1 098,04%
24,10%
549,74%
28,69%
Other operating expenses
20,99 млн
14,02 млн
-16,35 млн
9,85 млн
Net income
23,78 млн
203,65 млн
-17,16 млн
129,58 млн
Net profit margin
31,33%
52,04%
-27,14%
55,09%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-2,85 млн
-2,82 млн
-2,58 млн
-4,30 млн
Net interest expenses
-2,85 млн
-2,82 млн
-2,58 млн
-4,30 млн
Depreciation and amortization charges
8,09 млн
8,39 млн
10,08 млн
10,82 млн
EBITDA
12,82 млн
278,64 млн
15,00 млн
194,62 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору